Please login to the form below
Tofersen
This page shows the latest Tofersen news and features for those working in and with pharma, biotech and healthcare.
Biogen’s R&D chief Ehlers heads for the exit
There’s still plenty in the neuroscience pipeline however, including tofersen for amyotrophic lateral sclerosis (ALS) which stems from an alliance with antisense specialist Ionis and is due for a phase
Latest news
-
Biogen’s tofersen shows promise in slowing down ALS
Hope for subset of patients with wasting disease. Biogen has revealed promising preliminary data for tofersen, a potential treatment for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS). ... Tofersen is just one of seven candidates
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Senior Leader
-
Exceptionally competitive salary
-
Medical Editor
-
Competitive
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Novartis and smartpatient launch app experience for wet AMD patients
- FDA delays BMS’ liso-cel decision, citing COVID-19 travel restrictions
- GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine
- Finalists - PMEA
- CureVac says its COVID-19 vaccine can be stored at standard refrigerator temperature
- What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
- Environmental impact of in-person vs. virtual meetings
- Russia says its Sputnik V COVID-19 vaccine is 91.4% effective
- PMEA 2020: continuing to recognise excellence in improving patient outcomes
- The US celebrates five years of biosimilars on the market – a look to the past, present and future
- Live Webinar: Patient-Centered Digital Transformation
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
- ...
- Environmental impact of in-person vs. virtual meetings
- Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
- The US celebrates five years of biosimilars on the market – a look to the past, present and future
- Why the success of biosimilars in the US has been mixed...
Quick links
Infographics
